107 related articles for article (PubMed ID: 26196957)
1. Suppression of Poly(rC)-Binding Protein 4 (PCBP4) reduced cisplatin resistance in human maxillary cancer cells.
Ito Y; Narita N; Nomi N; Sugimoto C; Takabayashi T; Yamada T; Karaya K; Matsumoto H; Fujieda S
Sci Rep; 2015 Jul; 5():12360. PubMed ID: 26196957
[TBL] [Abstract][Full Text] [Related]
2. Suppression of SESN1 reduces cisplatin and hyperthermia resistance through increasing reactive oxygen species (ROS) in human maxillary cancer cells.
Narita N; Ito Y; Takabayashi T; Okamoto M; Imoto Y; Ogi K; Tokunaga T; Matsumoto H; Fujieda S
Int J Hyperthermia; 2018 Dec; 35(1):269-278. PubMed ID: 30300027
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.
Horibe S; Matsuda A; Tanahashi T; Inoue J; Kawauchi S; Mizuno S; Ueno M; Takahashi K; Maeda Y; Maegouchi T; Murakami Y; Yumoto R; Nagai J; Takano M
Life Sci; 2015 Mar; 124():31-40. PubMed ID: 25625243
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest.
Zhang D; Piao HL; Li YH; Qiu Q; Li DJ; Du MR; Tsang BK
Exp Mol Pathol; 2016 Jun; 100(3):506-13. PubMed ID: 27163202
[TBL] [Abstract][Full Text] [Related]
6. Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest.
Lützkendorf J; Wieduwild E; Nerger K; Lambrecht N; Schmoll HJ; Müller-Tidow C; Müller LP
PLoS One; 2017; 12(1):e0169921. PubMed ID: 28081228
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of GADD45A enhances chemosensitivity in melanoma.
Liu J; Jiang G; Mao P; Zhang J; Zhang L; Liu L; Wang J; Owusu L; Ren B; Tang Y; Li W
Sci Rep; 2018 Mar; 8(1):4111. PubMed ID: 29515153
[TBL] [Abstract][Full Text] [Related]
8. PMS2 expression in epithelial ovarian cancer is posttranslationally regulated by Akt and essential for platinum-induced apoptosis.
Jia J; Wang Z; Cai J; Zhang Y
Tumour Biol; 2016 Mar; 37(3):3059-69. PubMed ID: 26423401
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic amounts of cisplatin induce either checkpoint adaptation or apoptosis in a concentration-dependent manner in cancer cells.
Swift LH; Golsteyn RM
Biol Cell; 2016 May; 108(5):127-48. PubMed ID: 26871414
[TBL] [Abstract][Full Text] [Related]
10. Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer.
Fedoseienko A; Wieringa HW; Wisman GB; Duiker E; Reyners AK; Hofker MH; van der Zee AG; van de Sluis B; van Vugt MA
PLoS One; 2016; 11(10):e0165385. PubMed ID: 27788210
[TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells.
Höhn A; Krüger K; Skowron MA; Bormann S; Schumacher L; Schulz WA; Hoffmann MJ; Niegisch G; Fritz G
Oncotarget; 2016 Jul; 7(27):41320-41335. PubMed ID: 27191498
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis.
Zhang HT; Yang J; Liang GH; Gao XJ; Sang Y; Gui T; Liang ZJ; Tam MS; Zha ZG
J Cell Biochem; 2017 Dec; 118(12):4575-4586. PubMed ID: 28485543
[TBL] [Abstract][Full Text] [Related]
13. Carfilzomib enhances cisplatin-induced apoptosis in SK-N-BE(2)-M17 human neuroblastoma cells.
Lee SI; Jeong YJ; Yu AR; Kwak HJ; Cha JY; Kang I; Yeo EJ
Sci Rep; 2019 Mar; 9(1):5039. PubMed ID: 30911132
[TBL] [Abstract][Full Text] [Related]
14. KLF4 sensitizes the colon cancer cell HCT-15 to cisplatin by altering the expression of HMGB1 and hTERT.
Yadav SS; Kumar M; Varshney A; Yadava PK
Life Sci; 2019 Mar; 220():169-176. PubMed ID: 30716337
[TBL] [Abstract][Full Text] [Related]
15. Cell fate determination in cisplatin resistance and chemosensitization.
Luong KV; Wang L; Roberts BJ; Wahl JK; Peng A
Oncotarget; 2016 Apr; 7(17):23383-94. PubMed ID: 26993599
[TBL] [Abstract][Full Text] [Related]
16. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance.
Wansleben S; Davis E; Peres J; Prince S
Cell Death Dis; 2013 Oct; 4(10):e846. PubMed ID: 24113180
[TBL] [Abstract][Full Text] [Related]
17. Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation.
Yan W; Scoumanne A; Jung YS; Xu E; Zhang J; Zhang Y; Ren C; Sun P; Chen X
Genes Dev; 2016 Mar; 30(5):522-34. PubMed ID: 26915821
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of drug-resistant lung cancer via a nanogel capable of reactivating cisplatin and enhancing early apoptosis.
Sun M; He L; Fan Z; Tang R; Du J
Biomaterials; 2020 Oct; 257():120252. PubMed ID: 32738659
[TBL] [Abstract][Full Text] [Related]
19. Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis.
Wang Q; Cui K; Espin-Garcia O; Cheng D; Qiu X; Chen Z; Moore M; Bristow RG; Xu W; Der S; Liu G
PLoS One; 2013; 8(12):e82363. PubMed ID: 24349265
[TBL] [Abstract][Full Text] [Related]
20. Multiple signal transduction pathways are involved in G2/M growth arrest and apoptosis induced by the immunomodulator AS101 in multiple myeloma.
Naor Y; Hayun M; Sredni B; Don J
Leuk Lymphoma; 2013 Jan; 54(1):160-6. PubMed ID: 22712839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
